Try a new search

Format these results:

Searched for:

in-biosketch:yes

person:lindej01

Total Results:

266


Depression, affect and negative symptoms in schizophrenia

Lindenmayer, J P; Kay, S R
PMID: 2619979
ISSN: 0960-5371
CID: 73087

Ascorbic acid action in neuroleptic-associated amenorrhea [Letter]

Kanofsky, J D; Kay, S R; Lindenmayer, J P; Seifter, E
PMID: 2571621
ISSN: 0271-0749
CID: 139156

Distinction of schizoaffective from schizophrenic profile. Independent validation [Letter]

Lindenmayer, J P; Kay, S R; Van Praag, H
PMID: 2487183
ISSN: 0920-9964
CID: 73086

Borrelia burgdorferi infection in horses [Letter]

Lindenmayer, J; Weber, M; Onderdonk, A
PMID: 2722625
ISSN: 0003-1488
CID: 2450392

PANSS rating criteria: Negative scale (N)

Kay, Stanley R; Opler, Lewis A; Lindenmayer, Jean-Pierre
Presents the N Scale from the Positive and Negative Syndrome Scale (P
PSYCH:1990-13683-001
ISSN: 0007-1250
CID: 73101

High-dose naloxone in tardive dyskinesia

Lindenmayer JP; Gardner E; Goldberg E; Opler LA; Kay SR; van Praag HM; Weiner M; Zukin S
Tardive dyskinesia (TD) is thought to result from nigrostriatal dopaminergic supersensitivity secondary to prolonged neuroleptic exposure. Preclinical studies have demonstrated that the opiate antagonist naloxone can acutely reverse a haloperidol-induced hyperdopaminergic state. In a trial of high-dose naloxone, 20 patients with TD received i.v. naloxone (20 mg, 40 mg, and placebo) under double-blind conditions. At baseline and at regular postdrug intervals, patients were evaluated using a battery of motor, clinical, and neuropsychological measures to study effects on neurological, behavioral, and cognitive functions. There was a significant improvement in involuntary movements at 30 min postnaloxone, together with improvement in clinical ratings at that time point, as well as some cognitive changes. The implications of these findings for the putative functional relationship between dopaminergic and enkephalinergic systems in the nigrostriatal area are discussed
PMID: 3070611
ISSN: 0165-1781
CID: 32797

Ascorbic acid and dopamine activity [Letter]

Kanofsky, J D; Kay, S R; Lindenmayer, J P; Seifter, E
PMID: 3381943
ISSN: 0002-953x
CID: 139157

Reliability and validity of the positive and negative syndrome scale for schizophrenics

Kay SR; Opler LA; Lindenmayer JP
The Positive and Negative Syndrome Scale (PANSS) was developed out of the need for a well-operationalized method of assessing these syndromes in schizophrenia, including their relationship to one another and to global psychopathology. We surveyed 82 acute and chronic schizophrenics to analyze the psychometric properties of the four PANSS scales. The interrater reliabilities were in the 0.80's, and significant correlations emerged with corresponding criterion measures. The PANSS positive and negative scales were inversely intercorrelated once their shared association with general psychopathology had been partialed out. The results support the scales' reliability, criterion-related validity, and construct validity, while cross-validating some of our previous findings
PMID: 3363019
ISSN: 0165-1781
CID: 32799

The changing presentation of catatonia [Letter]

Kay SR; Kanofsky D; Lindenmayer JP; Opler LA
PMID: 2884892
ISSN: 0002-953x
CID: 32801

Catatonic schizophrenia and negative symptoms [Letter]

Kanofsky JD; Kay SR; Lindenmayer JP; Opler LA
PMID: 3567826
ISSN: 0706-7437
CID: 32803